PoliticsJust In - Classified

FDA Restricts Use of 2 Monoclonal Antibody Treatments


The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal antibody treatments for COVID-19, saying data show such treatments are “highly unlikely” to be active against the Omicron variant, currently the dominant strain in the country.

Monoclonal antibodies are laboratory-created proteins that mimic natural antibodies the body produces to fight off harmful pathogens, such as the CCP virus, also known as the novel coronavirus.

This content is for Classified Membership and LifeTime Patriot Membership members only.
Login Join Now
QNavy is a pool a 3 former Navy Officers, U.S. Navy & French Navy, who served proudly their countries, specialized in conflict analysis as per their respective skills & experience on Special Ops. #NavyVetUnited

“Bitcoin Mining Disinformation” by David – 1.25.22

Previous article

IDC Community Thought(s) – 1.25.22

Next article

You may also like


Comments are closed.

More in Politics